Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230283 | SCV000287670 | likely benign | Progressive sclerosing poliodystrophy | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705260 | SCV000514243 | likely benign | not provided | 2019-04-02 | criteria provided, single submitter | clinical testing | |
Wong Mito Lab, |
RCV000230283 | SCV000887085 | likely benign | Progressive sclerosing poliodystrophy | 2018-10-01 | criteria provided, single submitter | clinical testing | The NM_002693.2:c.3075G>A (NP_002684.1:p.Leu1025=) [GRCH38: NC_000015.10:g.89319257C>T] variant in POLG gene is interpretated to be a Likely Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BP4:Computational evidence/predictors indicate no impact on the POLG structure, function, or protein-protein interaction. BP7:The variant is silent with non predicted splice impact. Based on the evidence criteria codes applied, the variant is suggested to be Likely Benign. |
Center for Genomics, |
RCV000768051 | SCV000898896 | likely benign | Progressive sclerosing poliodystrophy; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b | 2021-11-11 | criteria provided, single submitter | clinical testing | POLG NM_002693 exon 19 p.Leu1025Leu (c.3075G>A): This variant has not been reported in the literature but is present in 11/126672 European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs146404260). This variant is present in ClinVar (Variation ID:239380). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. Of note, this variant is a silent variant and does not change the amino acid, reducing the probability that this variant is disease causing. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV001705260 | SCV004137626 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | POLG: BP4, BP7 |